Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 13  •  04:00PM ET
103.24
Dollar change
+0.01
Percentage change
0.01
%
Feb 13, 7:15 PMExact Sciences reports fiscal Q4 2025 results with non-GAAP EPS -$0.45 (+90% YoY) missing estimates and revenue $878.4M (+23% YoY) beating estimates, posts record Q4 revenue and FY 2025 revenue of $3.25B, and reiterates progress toward its pending Abbott acquisition.
Index- P/E- EPS (ttm)-1.10 Insider Own1.93% Shs Outstand190.80M Perf Week0.06%
Market Cap19.70B Forward P/E88.43 EPS next Y1.17 Insider Trans-0.70% Shs Float187.13M Perf Month0.96%
Enterprise Value21.27B PEG- EPS next Q-0.18 Inst Own88.11% Short Float3.55% Perf Quarter51.00%
Income-207.95M P/S6.07 EPS this Y123.72% Inst Trans-12.07% Short Ratio1.27 Perf Half Y129.47%
Sales3.25B P/B8.20 EPS next Y347.47% ROA-3.39% Short Interest6.65M Perf YTD1.65%
Book/sh12.58 P/C20.42 EPS next 5Y- ROE-8.66% 52W High103.54 -0.29% Perf Year104.07%
Cash/sh5.06 P/FCF55.21 EPS past 3/5Y32.20% 27.36% ROIC-4.25% 52W Low38.81 166.00% Perf 3Y57.84%
Dividend Est.- EV/EBITDA322.75 Sales past 3/5Y15.92% 16.84% Gross Margin69.69% Volatility0.25% 0.33% Perf 5Y-33.40%
Dividend TTM- EV/Sales6.55 EPS Y/Y TTM-353.69% Oper. Margin-4.79% ATR (14)0.41 Perf 10Y1658.77%
Dividend Ex-Date- Quick Ratio2.17 Sales Y/Y TTM17.69% Profit Margin-6.40% RSI (14)73.44 Recom2.81
Dividend Gr. 3/5Y- - Current Ratio2.43 EPS Q/Q90.29% SMA200.56% Beta1.41 Target Price104.00
Payout- Debt/Eq1.06 Sales Q/Q23.12% SMA501.16% Rel Volume0.41 Prev Close103.23
Employees7200 LT Debt/Eq1.04 EarningsFeb 13 AMC SMA20050.91% Avg Volume5.23M Price103.24
IPOJan 31, 2001 Option/ShortYes / Yes EPS/Sales Surpr.-317.05% 2.03% Trades Volume2,120,502 Change0.01%
Date Action Analyst Rating Change Price Target Change
Jan-20-26Downgrade Mizuho Outperform → Neutral $105
Jan-05-26Downgrade Evercore ISI Outperform → In-line $105
Apr-10-25Initiated Mizuho Outperform $60
Mar-13-25Initiated RBC Capital Mkts Sector Perform $52
Jan-23-25Initiated Barclays Overweight $70
Aug-28-24Initiated Wells Fargo Overweight $75
Jun-27-24Initiated Scotiabank Sector Outperform $70
Jun-03-24Resumed Jefferies Buy $75
Jan-02-24Upgrade The Benchmark Company Hold → Buy $91
Dec-14-23Initiated Guggenheim Buy $90
Feb-16-26 10:57PM
11:40AM
Feb-13-26 05:15PM
04:21PM
04:05PM
01:04PM Loading…
Feb-12-26 01:04PM
Feb-09-26 11:01AM
Feb-08-26 11:04PM
Feb-06-26 05:41PM
Feb-03-26 02:32PM
09:03AM
08:30AM
Feb-02-26 12:05PM
Jan-28-26 06:46AM
Jan-27-26 11:40AM
07:46AM Loading…
07:46AM
Jan-26-26 06:40AM
Jan-22-26 04:02PM
04:01PM
02:16PM
09:48AM
08:53AM
Jan-20-26 08:47AM
07:55AM
Jan-13-26 01:00PM
Jan-12-26 07:51AM
Jan-09-26 02:24PM
Jan-08-26 04:30PM
12:48PM
12:21PM
12:31PM Loading…
Jan-07-26 12:31PM
11:52AM
11:49AM
Jan-06-26 11:18AM
11:00AM
Jan-04-26 11:32PM
Dec-31-25 07:25AM
Dec-30-25 07:32AM
07:32AM
Dec-26-25 01:48PM
Dec-16-25 02:09PM
Dec-15-25 02:59PM
Dec-11-25 05:30PM
Dec-10-25 11:35PM
Dec-08-25 01:35AM
Dec-05-25 09:41AM
Dec-03-25 11:30AM
Dec-02-25 04:54AM
Dec-01-25 12:33PM
Nov-30-25 02:05AM
Nov-28-25 12:41PM
Nov-25-25 09:36AM
09:17AM
01:33AM
Nov-24-25 04:35PM
09:41AM
09:20AM
Nov-23-25 10:30PM
Nov-21-25 09:10AM
07:32AM
06:30AM
04:50AM
03:35AM
Nov-20-25 07:50PM
07:43PM
06:29PM
05:06PM
05:05PM
04:44PM
04:23PM
04:15PM
04:14PM
03:31PM
03:08PM
03:03PM
03:01PM
02:47PM
01:36PM
01:02PM
12:01PM
11:51AM
11:32AM
10:21AM
09:41AM
09:31AM
09:26AM
08:43AM
08:09AM
07:46AM
07:46AM
07:30AM
06:27AM
Nov-19-25 07:21PM
04:57PM
04:31PM
04:27PM
02:36PM
11:19AM
06:22AM
Nov-17-25 01:13PM
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ORVILLE JACOB AEVP, GM, ScreeningDec 23 '25Option Exercise0.0073,080069,511Dec 30 04:30 PM
Baranick BrianEVP, GM, Precision OncologyDec 23 '25Option Exercise0.0073,080066,487Dec 30 04:30 PM
Condella SarahEVP, Human ResourcesDec 23 '25Option Exercise0.0047,2080118,059Dec 30 04:30 PM
Herriott JamesSVP, General Counsel & SecDec 23 '25Option Exercise0.0033,780032,934Dec 30 04:30 PM
Bloomer AaronEVP, Chief Financial OfficerDec 23 '25Option Exercise0.0063,099059,571Dec 30 04:30 PM
ORVILLE JACOB AEVP, GM, ScreeningNov 19 '25Sale75.005,000375,00023,237Nov 21 05:30 PM
Herriott JamesSVP, General Counsel & SecNov 19 '25Sale70.001,00070,00011,585Nov 21 05:30 PM
ORVILLE JACOB AOfficerNov 19 '25Proposed Sale75.005,000375,000Nov 19 03:11 PM
Herriott JamesOfficerNov 19 '25Proposed Sale70.001,00070,000Nov 19 12:04 PM
Herriott JamesSVP, General Counsel & SecNov 04 '25Sale70.081,500105,12012,585Nov 06 05:29 PM
Baranick BrianEVP, GM, Precision OncologyNov 04 '25Sale70.082,858200,28922,368Nov 06 05:29 PM
Baranick BrianOfficerNov 04 '25Proposed Sale70.082,858200,289Nov 04 10:25 AM
Herriott JamesOfficerNov 04 '25Proposed Sale70.081,500105,120Nov 04 10:22 AM
Zanotti Katherine SDirectorOct 24 '25Sale65.0012,000780,00060,759Oct 27 08:35 PM
Zanotti Katherine SDirectorOct 24 '25Proposed Sale65.0012,000780,000Oct 24 11:08 AM
Herriott JamesSVP, General Counsel & SecOct 09 '25Sale60.001,50090,00014,085Oct 10 05:27 PM
Doyle James EdwardDirectorOct 09 '25Sale60.002,000120,00057,962Oct 10 05:25 PM
Herriott JamesOfficerOct 09 '25Proposed Sale60.001,50090,000Oct 09 11:23 AM
Doyle James EdwardDirectorOct 09 '25Proposed Sale60.002,000120,000Oct 09 11:18 AM
Doyle James EdwardDirectorAug 13 '25Sale42.021,48562,40059,962Aug 14 04:30 PM
Doyle James EdwardDirectorAug 13 '25Proposed Sale42.021,48562,400Aug 13 10:09 AM
ORVILLE JACOB AEVP, GM, ScreeningAug 05 '25Option Exercise0.005,350030,752Aug 07 05:30 PM
Baranick BrianEVP, GM, Precision OncologyAug 05 '25Option Exercise0.005,350027,943Aug 07 05:30 PM
Sebelius KathleenFormer DirectorJul 16 '25Proposed Sale53.118,164433,605Jul 16 04:22 PM
Zanotti Katherine SDirectorJun 13 '25Sale53.203,207170,61272,759Jun 16 05:30 PM
Zanotti Katherine SDirectorJun 13 '25Proposed Sale53.203,207170,612Jun 13 09:50 AM
Bloomer AaronEVP, Chief Financial OfficerApr 15 '25Option Exercise0.0024,460019,340Apr 17 04:30 PM
Conroy Kevin TPresident and CEOMar 07 '25Option Exercise22.3866,7231,493,2611,203,269Mar 10 05:00 PM
Herriott JamesSVP, General Counsel & SecFeb 28 '25Option Exercise0.004,265016,339Mar 04 04:48 PM
Conroy Kevin TPresident and CEOFeb 28 '25Option Exercise0.0040,31001,146,965Mar 04 04:47 PM
Baranick BrianEVP, GM, Precision OncologyFeb 28 '25Option Exercise0.009,673025,106Mar 04 04:44 PM
ORVILLE JACOB AEVP, GM, ScreeningFeb 28 '25Option Exercise0.009,673027,728Mar 04 04:40 PM
Condella SarahEVP, Human ResourcesFeb 28 '25Option Exercise0.007,738084,399Mar 04 04:37 PM
Condella SarahEVP, Human ResourcesFeb 25 '25Option Exercise0.003,954080,297Feb 26 08:00 PM
Baranick BrianEVP, GM, Precision OncologyFeb 25 '25Option Exercise0.003,954019,841Feb 26 08:00 PM
Herriott JamesSVP, General Counsel & SecFeb 25 '25Option Exercise0.001,647013,738Feb 26 08:00 PM
ORVILLE JACOB AEVP, GM, ScreeningFeb 25 '25Option Exercise0.003,954022,136Feb 26 08:00 PM
Conroy Kevin TPresident and CEOFeb 25 '25Option Exercise0.0013,18001,121,378Feb 26 08:00 PM
Conroy Kevin TPresident and CEOFeb 19 '25Option Exercise0.0010,37401,084,565Feb 21 04:30 PM
COWARD D SCOTTDirectorFeb 19 '25Option Exercise0.002,248052,831Feb 21 04:30 PM
ORVILLE JACOB AEVP, GM, ScreeningFeb 19 '25Option Exercise0.002,248016,688Feb 21 04:30 PM
Baranick BrianEVP, GM, Precision OncologyFeb 19 '25Option Exercise0.001,729014,487Feb 21 04:30 PM
Condella SarahEVP, Human ResourcesFeb 19 '25Option Exercise0.002,248074,859Feb 21 04:30 PM
Herriott JamesSVP, General Counsel & SecFeb 19 '25Option Exercise0.00865010,731Feb 21 04:30 PM
Last Close
Feb 13  •  04:00PM ET
31.25
Dollar change
-0.16
Percentage change
-0.51
%
PHG Koninklijke Philips N.V. ADR daily Stock Chart
Index- P/E29.24 EPS (ttm)1.07 Insider Own0.00% Shs Outstand951.29M Perf Week6.08%
Market Cap29.71B Forward P/E15.56 EPS next Y2.01 Insider Trans- Shs Float950.57M Perf Month3.82%
Enterprise Value35.96B PEG2.31 EPS next Q0.25 Inst Own5.07% Short Float0.18% Perf Quarter6.36%
Income1.03B P/S1.47 EPS this Y-3.32% Inst Trans1.09% Short Ratio2.07 Perf Half Y14.76%
Sales20.19B P/B2.31 EPS next Y11.76% ROA-2.88% Short Interest1.67M Perf YTD15.40%
Book/sh13.53 P/C9.05 EPS next 5Y6.75% ROE-7.07% 52W High33.44 -6.54% Perf Year9.23%
Cash/sh3.45 P/FCF29.04 EPS past 3/5Y- -5.02% ROIC4.89% 52W Low21.48 45.50% Perf 3Y99.42%
Dividend Est.0.98 (3.15%) EV/EBITDA11.36 Sales past 3/5Y2.42% 0.39% Gross Margin45.18% Volatility2.93% 1.92% Perf 5Y-42.12%
Dividend TTM0.89 (2.84%) EV/Sales1.78 EPS Y/Y TTM232.70% Oper. Margin9.38% ATR (14)0.89 Perf 10Y45.46%
Dividend Ex-DateMay 13, 2026 Quick Ratio0.94 Sales Y/Y TTM-0.77% Profit Margin5.09% RSI (14)60.48 Recom2.26
Dividend Gr. 3/5Y- 4.51% Current Ratio1.32 EPS Q/Q- SMA205.02% Beta0.76 Target Price33.44
Payout95.00% Debt/Eq0.74 Sales Q/Q10.26% SMA509.68% Rel Volume1.35 Prev Close31.41
Employees67823 LT Debt/Eq0.63 EarningsFeb 10 BMO SMA20016.74% Avg Volume810.81K Price31.25
IPOMar 17, 1980 Option/ShortYes / Yes EPS/Sales Surpr.26.60% 3.12% Trades Volume1,089,340 Change-0.51%
Date Action Analyst Rating Change Price Target Change
Dec-17-25Initiated RBC Capital Mkts Sector Perform
Feb-25-25Upgrade Exane BNP Paribas Neutral → Outperform
Feb-20-25Upgrade UBS Neutral → Buy
Oct-29-24Upgrade Jefferies Underperform → Hold
May-13-24Upgrade Bernstein Mkt Perform → Outperform
May-07-24Upgrade Exane BNP Paribas Underperform → Neutral
Apr-30-24Upgrade UBS Sell → Neutral
Apr-30-24Upgrade JP Morgan Underweight → Neutral
Feb-07-24Downgrade Exane BNP Paribas Outperform → Underperform
Jul-12-23Initiated Goldman Buy
Feb-12-26 09:00AM
Feb-11-26 12:16PM
11:48AM
04:00AM
Feb-10-26 06:44PM
12:25PM Loading…
12:25PM
10:01AM
09:41AM
08:18AM
05:27AM
05:27AM
05:24AM
05:09AM
04:04AM
03:13AM
03:01AM Loading…
03:01AM
02:18AM
01:00AM
12:55AM
Feb-09-26 07:18AM
Feb-04-26 06:01PM
Feb-03-26 04:00AM
Jan-29-26 01:00PM
Jan-27-26 01:01AM
Jan-23-26 07:48AM
Jan-22-26 10:31AM
Jan-21-26 05:00AM
Jan-16-26 06:07AM
Jan-15-26 09:09AM
05:22AM
08:26AM Loading…
Jan-12-26 08:26AM
Jan-07-26 09:40AM
Dec-17-25 06:21AM
Dec-15-25 09:08AM
07:25AM
02:00AM
Dec-04-25 12:28PM
12:21PM
08:11AM
07:14AM
Dec-01-25 08:00AM
Nov-30-25 12:00PM
11:40AM
Nov-24-25 09:00AM
Nov-19-25 09:00AM
Nov-17-25 08:00AM
Nov-04-25 01:30PM
10:01AM
06:24AM
01:49AM
01:00AM
Nov-03-25 08:30AM
Oct-30-25 08:06AM
Oct-29-25 05:00AM
Oct-27-25 09:00AM
Oct-24-25 09:40AM
Oct-22-25 11:40AM
09:40AM
09:15AM
Oct-08-25 09:40AM
04:00AM
Oct-07-25 03:00AM
Oct-06-25 11:40AM
09:50AM
09:40AM
Sep-26-25 10:00AM
Sep-25-25 09:00AM
Sep-23-25 09:55AM
09:01AM
Sep-17-25 09:00AM
Sep-15-25 04:00AM
Sep-11-25 08:00AM
08:00AM
Sep-10-25 09:40AM
07:17AM
Sep-04-25 09:00AM
07:00AM
Aug-27-25 09:00AM
Aug-25-25 09:40AM
09:00AM
Aug-20-25 11:20AM
09:00AM
Aug-18-25 07:35AM
04:33AM
Aug-15-25 09:50AM
Aug-14-25 12:00PM
Aug-12-25 12:03PM
Aug-08-25 09:40AM
Jul-30-25 12:53PM
03:02AM
Jul-29-25 02:03PM
06:39AM
05:25AM
04:49AM
04:31AM
03:46AM
01:50AM
01:15AM
01:00AM
Jul-28-25 09:50AM
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.
Last Close
Feb 13  •  04:00PM ET
67.54
Dollar change
-0.15
Percentage change
-0.22
%
FEZ State Street SPDR EURO Stoxx 50 ETF daily Stock Chart
CategoryGlobal or ExUS Equities - Broad / Regional Asset TypeEquities (Stocks) TagsEurope Return% 1Y28.56% Total Holdings56 Perf Week0.06%
SponsorState Street (SPDR) ETF Type Tagsequity Return% 3Y19.39% AUM5.29B Perf Month1.34%
Fund Family Bond Type Tagslarge-cap Return% 5Y12.78% NAV/sh Perf Quarter5.19%
IndexEURO STOXX 50 Index Average Maturity Tags- Return% 10Y 52W High68.68 -1.66% Perf Half Y11.54%
Index Weighting Commodity Type Tags- Return% SI 52W Low47.63 41.80% Perf YTD4.89%
Active/Passive Quant Type Tags- Flows% 1M-1.83% Volatility1.10% 1.11% Perf Year23.56%
Dividend TTM1.79 (2.65%) ESG Type Tags- Flows% 3M3.71% ATR (14)0.84 Perf 3Y54.52%
Dividend Ex-DateDec 22, 2025 Dividend Type Sector/Theme Flows% YTD0.84% RSI (14)54.95 Perf 5Y55.73%
Dividend Gr. 3/5Y14.90% 15.14% Structure Type Region Flows% 1Y Beta0.96 Perf 10Y122.76%
Expense0.29% Growth/Value SMA200.54% Flows% 3Y Rel Volume0.58 Prev Close67.69
Inverse/Leveraged Market Cap SMA502.60% Flows% 5Y Avg Volume1.71M Price67.54
IPOOct 21, 2002 Option/ShortYes / Yes SMA2009.28% Trades Volume994,336 Change-0.22%
Jan-22-26 09:50AM
Jan-09-26 08:27AM
Dec-31-25 07:00AM
Dec-11-25 01:45PM
01:45PM
11:16AM Loading…
Nov-13-25 11:16AM
Jul-24-25 06:20AM
Jun-06-25 11:30AM
May-07-25 11:50AM
11:30AM
07:05AM
May-05-25 08:41AM
07:04AM
May-03-25 03:40AM
12:30AM
11:15PM Loading…
May-02-25 11:15PM
07:45AM
06:00AM
May-01-25 02:10PM
04:00AM
Apr-30-25 07:42PM
09:36AM
04:35AM
04:10AM
03:35AM
Apr-29-25 06:35AM
04:35AM
03:15AM
02:35AM
Apr-28-25 05:30AM
04:22AM Loading…
Apr-26-25 04:22AM
Apr-25-25 07:40AM
04:20AM
03:45AM
Apr-24-25 07:22AM
05:50AM
Apr-23-25 07:25AM
07:07AM
05:45AM
04:30AM
03:10AM
Apr-22-25 11:03AM
Apr-19-25 02:25AM
Apr-17-25 12:06PM
11:27AM
05:35AM
04:30AM
03:20AM
Apr-16-25 05:00AM
04:05AM
02:40AM
Apr-15-25 10:15PM
03:46PM
11:58AM
11:35AM
08:40AM
08:40AM
07:45AM
04:52AM
04:30AM
04:10AM
Apr-14-25 02:30AM
Apr-12-25 05:00AM
12:30AM
Apr-11-25 05:05AM
04:30AM
Apr-10-25 08:00AM
04:30AM
Apr-09-25 08:23AM
04:50AM
Apr-08-25 06:20AM
04:25AM
Apr-07-25 12:30PM
11:48AM
Apr-04-25 02:30PM
04:55AM
04:00AM
03:40AM
Apr-03-25 10:45PM
09:40AM
05:05AM
02:32AM
02:15AM
Apr-02-25 05:30AM
05:30AM
03:30AM
12:50AM
Apr-01-25 11:51AM
07:29AM
04:20AM
12:16AM
Mar-29-25 05:45AM
02:50AM
02:45AM
12:50AM
Mar-28-25 11:05AM
05:00AM
03:55AM
Mar-27-25 05:20PM
08:19AM
SPDR EURO STOXX 50 ETF seeks investment results that, before fees and expenses, correspond generally to the total return performance of the EURO STOXX 50 Index. The fund employs a sampling strategy, which means that the fund is not required to purchase all of the securities represented in the index. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index is a market capitalization weighted index designed to represent the performance of some of the largest companies across components of the 20 EURO STOXX Supersector Indexes. The EURO STOXX Supersector Indexes are subsets of the EURO STOXX Index.